Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
cerebral palsy
MeSH D002547 - cerebral palsy
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D001925:
Chronic brain damage
0 Companies
0 Drugs
Success rate
D002547:
Cerebral palsy
35 Companies
2 Drugs
$
Success rate
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
71
%
10/14
Phase 2
92
%
12/13
Phase 3
23
%
6/26
Approved:
2
Overall Success rate:
15%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Dutetrabenazine
Mylan
Baclofen
Novartis
Baclofen
UCB
Baclofen
Impax Laboratories
Baclofen
1
2
3
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use